Practices
The problem
Teams often learn what a stage requires when an investor or a CDMO asks for it.
The cost: the plan is rewritten in a rush, in the weeks that matter most.
Roadmap by company stage
The topics a biotech team usually has to cover at each stage, from discovery to commercial.
Discovery
Finding and testing candidates in the lab.
- Lab records and data integrity
- Biosafety levels for your work
- Meeting and decision records
- Sample and reagent tracking
Preclinical
Testing a candidate in nonclinical studies.
IND-enabling
Preparing the data and material needed for a first-in-human trial.
- GLP toxicology studies
- The CMC section: manufacture, controls and specifications
- GMP manufacture of clinical material
- Pre-IND meeting with FDA
- IND assembly and submission
Phase 1
First studies in people, usually focused on safety.
- GCP and IRB oversight
- Clinical supply under GMP
- Safety reporting
- Deviations and CAPA
- Change control as the process changes
Phase 2
Studies of dose and early signs of effect.
- Process development and scale-up
- Analytical method qualification
- Supplier qualification
- Stability studies
- IND amendments
Phase 3
Larger studies that support a marketing application.
- Process validation planning
- Method validation
- Tech transfer to the commercial site
- CDMO oversight
- Data for the filing
Filing
Submitting the marketing application.
- NDA or BLA assembly
- The CMC section in final form
- Readiness for pre-approval inspection
- Electronic records and audit trails
Commercial
Making and selling the approved product.
- Commercial GMP manufacture and batch release
- Post-approval changes and annual reports
- Continued process verification
- Supplier and CDMO management
- Ongoing safety monitoring
Related
Pick your stage, then see the work SI 42 drafts for it.